Fluticasone Propionate; Salmeterol Xinafoate Patent Expiration
Fluticasone Propionate; Salmeterol Xinafoate was first introduced by Glaxo Group Ltd England Dba Glaxosmithkline
Fluticasone Propionate; Salmeterol Xinafoate Patents
Given below is the list of patents protecting Fluticasone Propionate; Salmeterol Xinafoate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Airduo Digihaler |
US11266796 (Pediatric) | Inhalation device with integrated electronics | Aug 22, 2041 | Teva Pharm |
| Airduo Digihaler | US11266796 | Inhalation device with integrated electronics | Feb 22, 2041 | Teva Pharm |
| Airduo Digihaler |
US11173259 (Pediatric) | Drug delivery device with electronics and power management | Jan 06, 2041 | Teva Pharm |
| Airduo Digihaler | US11173259 | Drug delivery device with electronics and power management | Jul 06, 2040 | Teva Pharm |
| Airduo Digihaler | US11464923 | Inhaler system | Jun 19, 2040 | Teva Pharm |
| Airduo Digihaler | US11439777 | Drug delivery device with electronics | May 24, 2040 | Teva Pharm |
| Airduo Digihaler |
US11344685 (Pediatric) | Drug delivery device with electronics | Mar 26, 2040 | Teva Pharm |
| Airduo Digihaler |
US11969544 (Pediatric) | Inhalers and airflow adaptors therefor | Feb 20, 2040 | Teva Pharm |
| Airduo Respiclick |
US11969544 (Pediatric) | Inhalers and airflow adaptors therefor | Feb 20, 2040 | Teva Pharm |
| Airduo Digihaler | US11344685 | Drug delivery device with electronics | Sep 26, 2039 | Teva Pharm |
| Airduo Digihaler | US11969544 | Inhalers and airflow adaptors therefor | Aug 20, 2039 | Teva Pharm |
| Airduo Respiclick | US11969544 | Inhalers and airflow adaptors therefor | Aug 20, 2039 | Teva Pharm |
| Airduo Digihaler |
US11000653 (Pediatric) | Inhaler | Jun 18, 2039 | Teva Pharm |
| Airduo Digihaler | US11000653 | Inhaler | Dec 18, 2038 | Teva Pharm |
| Airduo Digihaler | US11357935 | Drug delivery device with electronics | Sep 24, 2038 | Teva Pharm |
| Airduo Digihaler |
US11351317 (Pediatric) | Drug delivery device with electronics | Aug 10, 2038 | Teva Pharm |
| Airduo Digihaler | US11351317 | Drug delivery device with electronics | Feb 10, 2038 | Teva Pharm |
| Airduo Digihaler |
US10569034 (Pediatric) | Compliance monitoring module for a breath-actuated inhaler | Feb 16, 2037 | Teva Pharm |
| Airduo Digihaler | US10569034 | Compliance monitoring module for a breath-actuated inhaler | Aug 16, 2036 | Teva Pharm |
| Airduo Digihaler |
US10918816 (Pediatric) | Compliance monitoring module for a breath-actuated inhaler | Jun 14, 2036 | Teva Pharm |
| Airduo Digihaler |
US9782550 (Pediatric) | Compliance monitoring module for a breath-actuated inhaler | Feb 28, 2036 | Teva Pharm |
| Airduo Digihaler |
US9782551 (Pediatric) | Compliance monitoring module for a breath-actuated inhaler | Feb 28, 2036 | Teva Pharm |
| Airduo Digihaler | US10918816 | Compliance monitoring module for a breath-actuated inhaler | Dec 14, 2035 | Teva Pharm |
| Airduo Digihaler | US9782550 | Compliance monitoring module for a breath-actuated inhaler | Aug 28, 2035 | Teva Pharm |
| Airduo Digihaler | US9782551 | Compliance monitoring module for a breath-actuated inhaler | Aug 28, 2035 | Teva Pharm |
| Airduo Digihaler |
US9066957 (Pediatric) | Dry powder inhaler | Apr 06, 2035 | Teva Pharm |
| Airduo Digihaler |
US9415008 (Pediatric) | Dry powder inhaler | Apr 06, 2035 | Teva Pharm |
| Airduo Respiclick |
US9066957 (Pediatric) | Dry powder inhaler | Apr 06, 2035 | Teva Pharm |
| Airduo Respiclick |
US9415008 (Pediatric) | Dry powder inhaler | Apr 06, 2035 | Teva Pharm |
| Airduo Digihaler | US9066957 | Dry powder inhaler | Oct 06, 2034 | Teva Pharm |
| Airduo Digihaler | US9415008 | Dry powder inhaler | Oct 06, 2034 | Teva Pharm |
| Airduo Respiclick | US9066957 | Dry powder inhaler | Oct 06, 2034 | Teva Pharm |
| Airduo Respiclick | US9415008 | Dry powder inhaler | Oct 06, 2034 | Teva Pharm |
| Airduo Digihaler |
US8714149 (Pediatric) | Airflow adaptor for a breath-actuated dry powder inhaler | Aug 25, 2032 | Teva Pharm |
| Airduo Respiclick |
US8714149 (Pediatric) | Airflow adaptor for a breath-actuated dry powder inhaler | Aug 25, 2032 | Teva Pharm |
| Airduo Digihaler |
US8978966 (Pediatric) | Dose counters for inhalers, inhalers and methods of assembly thereof | Jul 13, 2032 | Teva Pharm |
| Airduo Respiclick |
US8978966 (Pediatric) | Dose counters for inhalers, inhalers and methods of assembly thereof | Jul 13, 2032 | Teva Pharm |
| Airduo Digihaler |
US10561808 (Pediatric) | Dose counter for inhaler having an anti-reverse rotation actuator | Jul 01, 2032 | Teva Pharm |
| Airduo Respiclick |
US10561808 (Pediatric) | Dose counter for inhaler having an anti-reverse rotation actuator | Jul 01, 2032 | Teva Pharm |
| Airduo Digihaler | US8714149 | Airflow adaptor for a breath-actuated dry powder inhaler | Feb 25, 2032 | Teva Pharm |
| Airduo Respiclick | US8714149 | Airflow adaptor for a breath-actuated dry powder inhaler | Feb 25, 2032 | Teva Pharm |
| Airduo Digihaler | US8978966 | Dose counters for inhalers, inhalers and methods of assembly thereof | Jan 13, 2032 | Teva Pharm |
| Airduo Respiclick | US8978966 | Dose counters for inhalers, inhalers and methods of assembly thereof | Jan 13, 2032 | Teva Pharm |
| Airduo Digihaler | US10561808 | Dose counter for inhaler having an anti-reverse rotation actuator | Jan 01, 2032 | Teva Pharm |
| Airduo Respiclick | US10561808 | Dose counter for inhaler having an anti-reverse rotation actuator | Jan 01, 2032 | Teva Pharm |
| Airduo Digihaler |
US9216260 (Pediatric) | Dose counters for inhalers, inhalers and methods of assembly thereof | Dec 28, 2031 | Teva Pharm |
| Airduo Respiclick |
US9216260 (Pediatric) | Dose counters for inhalers, inhalers and methods of assembly thereof | Dec 28, 2031 | Teva Pharm |
| Airduo Digihaler |
US10022510 (Pediatric) | Dose counters for inhalers, inhalers and methods of assembly thereof | Nov 18, 2031 | Teva Pharm |
| Airduo Digihaler |
US10124131 (Pediatric) | Dose counter for inhaler having an anti-reverse rotation actuator | Nov 18, 2031 | Teva Pharm |
| Airduo Digihaler |
US9731087 (Pediatric) | Dose counter for inhaler having a bore and shaft arrangement | Nov 18, 2031 | Teva Pharm |
| Airduo Respiclick |
US10022510 (Pediatric) | Dose counters for inhalers, inhalers and methods of assembly thereof | Nov 18, 2031 | Teva Pharm |
| Airduo Respiclick |
US10124131 (Pediatric) | Dose counter for inhaler having an anti-reverse rotation actuator | Nov 18, 2031 | Teva Pharm |
| Airduo Respiclick |
US9731087 (Pediatric) | Dose counter for inhaler having a bore and shaft arrangement | Nov 18, 2031 | Teva Pharm |
| Airduo Digihaler |
US10195375 (Pediatric) | Airflow adaptor for a breath-actuated dry powder inhaler | Aug 14, 2031 | Teva Pharm |
| Airduo Respiclick |
US10195375 (Pediatric) | Airflow adaptor for a breath-actuated dry powder inhaler | Aug 14, 2031 | Teva Pharm |
| Airduo Digihaler | US9216260 | Dose counters for inhalers, inhalers and methods of assembly thereof | Jun 28, 2031 | Teva Pharm |
| Airduo Respiclick | US9216260 | Dose counters for inhalers, inhalers and methods of assembly thereof | Jun 28, 2031 | Teva Pharm |
| Airduo Digihaler | US10022510 | Dose counters for inhalers, inhalers and methods of assembly thereof | May 18, 2031 | Teva Pharm |
| Airduo Digihaler | US10124131 | Dose counter for inhaler having an anti-reverse rotation actuator | May 18, 2031 | Teva Pharm |
| Airduo Digihaler | US9731087 | Dose counter for inhaler having a bore and shaft arrangement | May 18, 2031 | Teva Pharm |
| Airduo Respiclick | US10022510 | Dose counters for inhalers, inhalers and methods of assembly thereof | May 18, 2031 | Teva Pharm |
| Airduo Respiclick | US10124131 | Dose counter for inhaler having an anti-reverse rotation actuator | May 18, 2031 | Teva Pharm |
| Airduo Respiclick | US9731087 | Dose counter for inhaler having a bore and shaft arrangement | May 18, 2031 | Teva Pharm |
| Airduo Digihaler | US10195375 | Airflow adaptor for a breath-actuated dry powder inhaler | Feb 14, 2031 | Teva Pharm |
| Airduo Respiclick | US10195375 | Airflow adaptor for a breath-actuated dry powder inhaler | Feb 14, 2031 | Teva Pharm |
| Airduo Digihaler |
US8651103 (Pediatric) | Dry powder inhalation apparatus | Sep 26, 2028 | Teva Pharm |
| Airduo Respiclick |
US8651103 (Pediatric) | Dry powder inhalation apparatus | Sep 26, 2028 | Teva Pharm |
| Airduo Digihaler | US8651103 | Dry powder inhalation apparatus | Mar 26, 2028 | Teva Pharm |
| Airduo Respiclick | US8651103 | Dry powder inhalation apparatus | Mar 26, 2028 | Teva Pharm |
| Advair Hfa |
US7500444 (Pediatric) | Actuation indicator for a dispensing device | Aug 26, 2026 | Glaxo Grp Ltd |
| Advair Hfa | US7500444 | Actuation indicator for a dispensing device | Feb 26, 2026 | Glaxo Grp Ltd |
| Airduo Digihaler |
US10765820 (Pediatric) | Dry powder inhalation apparatus | Nov 19, 2025 | Teva Pharm |
| Airduo Digihaler |
US9463288 (Pediatric) | Dry powder inhalation apparatus | Nov 19, 2025 | Teva Pharm |
| Airduo Respiclick |
US10765820 (Pediatric) | Dry powder inhalation apparatus | Nov 19, 2025 | Teva Pharm |
| Airduo Respiclick |
US9463288 (Pediatric) | Dry powder inhalation apparatus | Nov 19, 2025 | Teva Pharm |
| Advair Hfa |
US7500444 (Pediatric) | Actuation indicator for a dispensing device | Jul 04, 2025 | Glaxo Grp Ltd |
| Airduo Digihaler | US10765820 | Dry powder inhalation apparatus | May 19, 2025 | Teva Pharm |
| Airduo Digihaler | US9463288 | Dry powder inhalation apparatus | May 19, 2025 | Teva Pharm |
| Airduo Respiclick | US10765820 | Dry powder inhalation apparatus | May 19, 2025 | Teva Pharm |
| Airduo Respiclick | US9463288 | Dry powder inhalation apparatus | May 19, 2025 | Teva Pharm |
| Airduo Digihaler |
US9616024 (Pediatric) | Process for preparing a medicament | Mar 01, 2025 | Teva Pharm |
| Airduo Digihaler |
US9987229 (Pediatric) | Process for preparing a medicament | Mar 01, 2025 | Teva Pharm |
| Airduo Respiclick |
US9616024 (Pediatric) | Process for preparing a medicament | Mar 01, 2025 | Teva Pharm |
| Airduo Respiclick |
US9987229 (Pediatric) | Process for preparing a medicament | Mar 01, 2025 | Teva Pharm |
| Advair Hfa | US7500444 | Actuation indicator for a dispensing device | Jan 04, 2025 | Glaxo Grp Ltd |
| Airduo Digihaler | US9616024 | Process for preparing a medicament |
Sep 01, 2024
(Expired) | Teva Pharm |
| Airduo Digihaler | US9987229 | Process for preparing a medicament |
Sep 01, 2024
(Expired) | Teva Pharm |
| Airduo Respiclick | US9616024 | Process for preparing a medicament |
Sep 01, 2024
(Expired) | Teva Pharm |
| Airduo Respiclick | US9987229 | Process for preparing a medicament |
Sep 01, 2024
(Expired) | Teva Pharm |
| Advair Hfa |
US7832351 (Pediatric) | Actuation indicator for a dispensing device |
Dec 19, 2023
(Expired) | Glaxo Grp Ltd |
| Airduo Digihaler |
US7540282 (Pediatric) | Reservoir pressure system for medicament inhaler |
Nov 06, 2023
(Expired) | Teva Pharm |
| Airduo Respiclick |
US7540282 (Pediatric) | Reservoir pressure system for medicament inhaler |
Nov 06, 2023
(Expired) | Teva Pharm |
| Advair Hfa | US7832351 | Actuation indicator for a dispensing device |
Jun 19, 2023
(Expired) | Glaxo Grp Ltd |
| Airduo Digihaler | US7540282 | Reservoir pressure system for medicament inhaler |
May 06, 2023
(Expired) | Teva Pharm |
| Airduo Respiclick | US7540282 | Reservoir pressure system for medicament inhaler |
May 06, 2023
(Expired) | Teva Pharm |
| Advair Hfa |
US6743413 (Pediatric) | Suspension aerosol formulations |
Dec 01, 2021
(Expired) | Glaxo Grp Ltd |
| Airduo Digihaler | US6701917 | Dose counter for medicament inhaler |
Jun 23, 2021
(Expired) | Teva Pharm |
| Airduo Digihaler | US6718972 | Dose metering system for medicament inhaler |
Jun 23, 2021
(Expired) | Teva Pharm |
| Airduo Digihaler | US6748947 | De-agglomerator for breath-actuated dry powder inhaler |
Jun 23, 2021
(Expired) | Teva Pharm |
| Airduo Digihaler | US6871646 | De-agglomerator for breath-actuated dry powder inhaler |
Jun 23, 2021
(Expired) | Teva Pharm |
| Airduo Digihaler | US8006690 | Reservoir pressure system for medicament inhaler |
Jun 23, 2021
(Expired) | Teva Pharm |
| Airduo Respiclick | US6701917 | Dose counter for medicament inhaler |
Jun 23, 2021
(Expired) | Teva Pharm |
| Airduo Respiclick | US6718972 | Dose metering system for medicament inhaler |
Jun 23, 2021
(Expired) | Teva Pharm |
| Airduo Respiclick | US6748947 | De-agglomerator for breath-actuated dry powder inhaler |
Jun 23, 2021
(Expired) | Teva Pharm |
| Airduo Respiclick | US6871646 | De-agglomerator for breath-actuated dry powder inhaler |
Jun 23, 2021
(Expired) | Teva Pharm |
| Airduo Respiclick | US8006690 | Reservoir pressure system for medicament inhaler |
Jun 23, 2021
(Expired) | Teva Pharm |
| Advair Hfa | US6743413 | Suspension aerosol formulations |
Jun 01, 2021
(Expired) | Glaxo Grp Ltd |
| Advair Hfa | US9861771 | Device housing for an aerosol container |
Oct 11, 2020
(Expired) | Glaxo Grp Ltd |
| Advair Hfa |
US7350676 (Pediatric) | Valve for aerosol container |
Feb 24, 2019
(Expired) | Glaxo Grp Ltd |
| Advair Hfa |
US6431168 (Pediatric) | Dispenser with doses′ counter |
Dec 08, 2018
(Expired) | Glaxo Grp Ltd |
| Advair Hfa |
US7107986 (Pediatric) | Dispenser with doses' counter |
Dec 08, 2018
(Expired) | Glaxo Grp Ltd |
| Advair Hfa | US7350676 | Valve for aerosol container |
Aug 24, 2018
(Expired) | Glaxo Grp Ltd |
| Advair Hfa |
US6161724 (Pediatric) | Indicating device |
Jul 16, 2018
(Expired) | Glaxo Grp Ltd |
| Advair Hfa |
US6435372 (Pediatric) | Delivery system for a medicament and method for the assembly thereof |
Jul 16, 2018
(Expired) | Glaxo Grp Ltd |
| Advair Hfa |
US6938796 (Pediatric) | Indicating device |
Jul 16, 2018
(Expired) | Glaxo Grp Ltd |
| Advair Hfa |
US6997349 (Pediatric) | Indicating device |
Jul 16, 2018
(Expired) | Glaxo Grp Ltd |
| Advair Hfa |
US7143908 (Pediatric) | Indicating device |
Jul 16, 2018
(Expired) | Glaxo Grp Ltd |
| Advair Hfa |
US6170717 (Pediatric) | Valve for aerosol container |
Jun 23, 2018
(Expired) | Glaxo Grp Ltd |
| Advair Hfa |
US6315173 (Pediatric) | Valve for aerosol container |
Jun 23, 2018
(Expired) | Glaxo Grp Ltd |
| Advair Hfa |
US6510969 (Pediatric) | Valve for aerosol container |
Jun 23, 2018
(Expired) | Glaxo Grp Ltd |
| Advair Hfa |
US6966467 (Pediatric) | Valve for aerosol container |
Jun 23, 2018
(Expired) | Glaxo Grp Ltd |
| Advair Hfa | US6431168 | Dispenser with doses′ counter |
Jun 08, 2018
(Expired) | Glaxo Grp Ltd |
| Advair Hfa | US7107986 | Dispenser with doses' counter |
Jun 08, 2018
(Expired) | Glaxo Grp Ltd |
| Advair Hfa | US6161724 | Indicating device |
Jan 16, 2018
(Expired) | Glaxo Grp Ltd |
| Advair Hfa | US6435372 | Delivery system for a medicament and method for the assembly thereof |
Jan 16, 2018
(Expired) | Glaxo Grp Ltd |
| Advair Hfa | US6938796 | Indicating device |
Jan 16, 2018
(Expired) | Glaxo Grp Ltd |
| Advair Hfa | US6997349 | Indicating device |
Jan 16, 2018
(Expired) | Glaxo Grp Ltd |
| Advair Hfa | US7143908 | Indicating device |
Jan 16, 2018
(Expired) | Glaxo Grp Ltd |
| Advair Hfa | US6170717 | Valve for aerosol container |
Dec 23, 2017
(Expired) | Glaxo Grp Ltd |
| Advair Hfa | US6315173 | Valve for aerosol container |
Dec 23, 2017
(Expired) | Glaxo Grp Ltd |
| Advair Hfa | US6510969 | Valve for aerosol container |
Dec 23, 2017
(Expired) | Glaxo Grp Ltd |
| Advair Hfa | US6966467 | Valve for aerosol container |
Dec 23, 2017
(Expired) | Glaxo Grp Ltd |
| Airduo Respiclick | US6446627 | Inhaler dose counter |
Dec 18, 2017
(Expired) | Teva Pharm |
| Advair Diskus 100/50 |
US5873360 (Pediatric) | Inhalation device |
Aug 23, 2016
(Expired) | Glaxo Grp Ltd |
| Advair Diskus 250/50 |
US5873360 (Pediatric) | Inhalation device |
Aug 23, 2016
(Expired) | Glaxo Grp Ltd |
| Advair Diskus 500/50 |
US5873360 (Pediatric) | Inhalation device |
Aug 23, 2016
(Expired) | Glaxo Grp Ltd |
| Advair Diskus 100/50 | US5873360 | Inhalation device |
Feb 23, 2016
(Expired) | Glaxo Grp Ltd |
| Advair Diskus 250/50 | US5873360 | Inhalation device |
Feb 23, 2016
(Expired) | Glaxo Grp Ltd |
| Advair Diskus 500/50 | US5873360 | Inhalation device |
Feb 23, 2016
(Expired) | Glaxo Grp Ltd |
| Advair Hfa |
US5674472 (Pediatric) | Canisters containing aerosol formulations containing P134a and fluticasone propionate |
Apr 07, 2015
(Expired) | Glaxo Grp Ltd |
| Advair Hfa |
US5658549 (Pediatric) | Aerosol formulations containing propellant 134a and fluticasone propionate |
Feb 19, 2015
(Expired) | Glaxo Grp Ltd |
| Advair Hfa |
US6596260 (Pediatric) | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
Feb 10, 2015
(Expired) | Glaxo Grp Ltd |
| Advair Hfa | US5674472 | Canisters containing aerosol formulations containing P134a and fluticasone propionate |
Oct 07, 2014
(Expired) | Glaxo Grp Ltd |
| Advair Hfa | US5658549 | Aerosol formulations containing propellant 134a and fluticasone propionate |
Aug 19, 2014
(Expired) | Glaxo Grp Ltd |
| Advair Hfa | US6596260 | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
Aug 10, 2014
(Expired) | Glaxo Grp Ltd |
| Advair Hfa |
US6251368 (Pediatric) | Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant |
Jun 04, 2013
(Expired) | Glaxo Grp Ltd |
| Advair Hfa | US6251368 | Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant |
Dec 04, 2012
(Expired) | Glaxo Grp Ltd |
Fluticasone Propionate; Salmeterol Xinafoate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List
Fluticasone Propionate; Salmeterol Xinafoate Generic API Manufacturers
Several generic applications have been filed for Fluticasone Propionate; Salmeterol Xinafoate. The first generic version for Fluticasone Propionate; Salmeterol Xinafoate was by Mylan Pharmaceuticals Inc and was approved on Jan 30, 2019. And the latest generic version is by Hikma Pharmaceuticals Usa Inc and was approved on Dec 19, 2023.
Given below is the list of companies who have filed for Fluticasone Propionate; Salmeterol Xinafoate generic, along with the locations of their manufacturing plants worldwide.
1. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Fluticasone Propionate; Salmeterol Xinafoate. All of these versions come by the name FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1MG/INH; EQ 0.05MG BASE/INH | powder | Prescription | INHALATION | AB | Dec 17, 2020 |
| 0.25MG/INH; EQ 0.05MG BASE/INH | powder | Prescription | INHALATION | AB | Dec 17, 2020 |
| 0.5MG/INH; EQ 0.05MG BASE/INH | powder | Prescription | INHALATION | AB | Dec 19, 2023 |
Manufacturing Plant Locations New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||
| Portugal |
| |||||||||
| Jordan |
| |||||||||
2. MYLAN
Mylan Pharmaceuticals Inc has filed for 3 different strengths of generic version for Fluticasone Propionate; Salmeterol Xinafoate. All of these versions come by the name WIXELA INHUB. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.5MG/INH; EQ 0.05MG BASE/INH | powder | Prescription | INHALATION | AB | Jan 30, 2019 |
| 0.1MG/INH; EQ 0.05MG BASE/INH | powder | Prescription | INHALATION | AB | Jan 30, 2019 |
| 0.25MG/INH; EQ 0.05MG BASE/INH | powder | Prescription | INHALATION | AB | Jan 30, 2019 |
Manufacturing Plant Locations New
Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
| India |
| |||||||||||||||||
| Canada |
| |||||||||||||||||
| Ireland |
| |||||||||||||||||
3. TEVA PHARMS USA
Teva Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Fluticasone Propionate; Salmeterol Xinafoate. All of these versions come by the name FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.25MG/INH; EQ 0.05MG BASE/INH | powder | Prescription | INHALATION | AB | Dec 13, 2021 |
| 0.5MG/INH; EQ 0.05MG BASE/INH | powder | Prescription | INHALATION | AB | Dec 13, 2021 |
| 0.1MG/INH; EQ 0.05MG BASE/INH | powder | Prescription | INHALATION | AB | Dec 13, 2021 |